Calcium Supplementation
Treatment for Premenstrual Syndrome
Typical Dosage: 1000-1200mg daily
Effectiveness
55%
Safety Score
85%
Clinical Trials
1
Participants
4K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
85
DangerousModerateSafe
Treatment Details
Dosage Range
1000-1200mg daily
Time to Effect
2-3 months
Treatment Duration
Continuous
Evidence Quality
MODERATENumber Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Confidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$40
Monitoring:$600
Side Effect Mgmt:$10
Total Annual:$650
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$1,000/QALY
QALYs Gained
0.03
Outcome-Based Costs
Cost per Responder
$111
Cost per Remission
$250
Calcium Supplementation Outcomes
for Premenstrual Syndrome
Efficacy Outcomes
Overall Effectiveness
+55%
Response Rate
+45%
Remission Rate
+20%
Common Side Effects
Constipation
+5%
Bloating
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
1 completed trial for Calcium Supplementation in Premenstrual Syndrome
Effectiveness of Non-hormonal Treatment on Moderate to Severe Premenstrual Syndrome
NCT07078708COMPLETEDNA
100 participants
INTERVENTIONAL
Lahore, Pakistan
Started: Jun 1, 2024